Fractyl Health (GUTS) Competitors $1.26 -0.02 (-1.56%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$1.25 -0.01 (-0.40%) As of 04/25/2025 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GUTS vs. STIM, SMTI, ZIMV, RCEL, SNWV, NVRO, NYXH, ELMD, PDEX, and DRTSShould you be buying Fractyl Health stock or one of its competitors? The main competitors of Fractyl Health include Neuronetics (STIM), Sanara MedTech (SMTI), ZimVie (ZIMV), AVITA Medical (RCEL), SANUWAVE Health (SNWV), Nevro (NVRO), Nyxoah (NYXH), Electromed (ELMD), Pro-Dex (PDEX), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry. Fractyl Health vs. Neuronetics Sanara MedTech ZimVie AVITA Medical SANUWAVE Health Nevro Nyxoah Electromed Pro-Dex Alpha Tau Medical Fractyl Health (NASDAQ:GUTS) and Neuronetics (NASDAQ:STIM) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, community ranking, profitability, institutional ownership, valuation and earnings. Does the MarketBeat Community believe in GUTS or STIM? Neuronetics received 124 more outperform votes than Fractyl Health when rated by MarketBeat users. However, 100.00% of users gave Fractyl Health an outperform vote while only 68.62% of users gave Neuronetics an outperform vote. CompanyUnderperformOutperformFractyl HealthOutperform Votes5100.00% Underperform VotesNo VotesNeuroneticsOutperform Votes12968.62% Underperform Votes5931.38% Do insiders and institutionals hold more shares of GUTS or STIM? 53.6% of Neuronetics shares are owned by institutional investors. 9.8% of Neuronetics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media prefer GUTS or STIM? In the previous week, Neuronetics had 5 more articles in the media than Fractyl Health. MarketBeat recorded 6 mentions for Neuronetics and 1 mentions for Fractyl Health. Fractyl Health's average media sentiment score of 1.87 beat Neuronetics' score of 0.65 indicating that Fractyl Health is being referred to more favorably in the media. Company Overall Sentiment Fractyl Health Very Positive Neuronetics Positive Do analysts recommend GUTS or STIM? Fractyl Health currently has a consensus price target of $11.00, indicating a potential upside of 773.02%. Neuronetics has a consensus price target of $5.50, indicating a potential upside of 22.77%. Given Fractyl Health's stronger consensus rating and higher probable upside, analysts clearly believe Fractyl Health is more favorable than Neuronetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fractyl Health 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Neuronetics 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has more volatility and risk, GUTS or STIM? Fractyl Health has a beta of 0.3, meaning that its stock price is 70% less volatile than the S&P 500. Comparatively, Neuronetics has a beta of 1.97, meaning that its stock price is 97% more volatile than the S&P 500. Which has preferable valuation and earnings, GUTS or STIM? Neuronetics has higher revenue and earnings than Fractyl Health. Neuronetics is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFractyl Health$93K662.79-$77.09M-$1.53-0.82Neuronetics$74.89M3.94-$30.19M-$1.37-3.27 Is GUTS or STIM more profitable? Neuronetics has a net margin of -50.09% compared to Fractyl Health's net margin of -64,849.48%. Fractyl Health's return on equity of 0.00% beat Neuronetics' return on equity.Company Net Margins Return on Equity Return on Assets Fractyl Health-64,849.48% N/A -57.21% Neuronetics -50.09%-141.24%-32.77% SummaryNeuronetics beats Fractyl Health on 10 of the 17 factors compared between the two stocks. Get Fractyl Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GUTS vs. The Competition Export to ExcelMetricFractyl HealthSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$61.64M$4.33B$5.47B$7.82BDividend YieldN/A46.43%5.43%4.27%P/E Ratio-0.1030.7422.3918.44Price / Sales662.7953.00391.43101.46Price / CashN/A51.0838.1834.62Price / BookN/A6.146.684.19Net Income-$77.09M$68.15M$3.22B$248.05M7 Day Performance3.28%4.65%6.25%6.54%1 Month PerformanceN/A-6.33%-2.70%-1.97%1 Year Performance-81.19%28.36%16.86%4.72% Fractyl Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GUTSFractyl Health1.7274 of 5 stars$1.26-1.6%$11.00+773.0%-81.2%$61.64M$93,000.00-0.10102STIMNeuronetics1.318 of 5 stars$3.88+3.2%$5.50+41.8%+28.4%$255.36M$74.89M-3.15180SMTISanara MedTech1.8281 of 5 stars$28.66-2.6%$48.50+69.2%-1.9%$255.13M$86.67M-28.9560ZIMVZimVie2.6256 of 5 stars$8.92-5.0%$19.50+118.6%-40.3%$248.40M$449.75M-0.682,700Positive NewsRCELAVITA Medical1.7017 of 5 stars$9.10-1.2%$17.25+89.6%+18.2%$240.56M$64.25M-3.81130Positive NewsSNWVSANUWAVE HealthN/A$28.00-6.6%N/AN/A$239.37M$32.63M-7.1840NVRONevro0.7605 of 5 stars$5.85+0.1%$5.36-8.3%-48.4%$224.32M$408.52M-3.091,090Analyst ForecastNYXHNyxoah2.2239 of 5 stars$5.94-1.5%$14.50+144.1%-44.7%$202.32M$4.52M-3.18110ELMDElectromed0.6523 of 5 stars$22.62-0.7%$38.00+68.0%+45.1%$193.56M$59.63M30.16160PDEXPro-Dex1.4283 of 5 stars$58.31-4.1%$52.00-10.8%+252.3%$190.15M$61.00M29.01140Upcoming EarningsShort Interest ↑News CoveragePositive NewsDRTSAlpha Tau Medical2.2826 of 5 stars$2.64+2.7%$8.00+203.0%+9.5%$185.81MN/A-6.1480Positive News Related Companies and Tools Related Companies Neuronetics Alternatives Sanara MedTech Alternatives ZimVie Alternatives AVITA Medical Alternatives SANUWAVE Health Alternatives Nevro Alternatives Nyxoah Alternatives Electromed Alternatives Pro-Dex Alternatives Alpha Tau Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GUTS) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fractyl Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fractyl Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GUTS Stock Free GUTS Stock Alerts